Superworth

Zoetis forward PE ZTS

Share price divided by analysts' consensus earnings for the next twelve months, since 2013.

Today, Oct 23, 2026
13.1×
10-year median
30.5×
Against its 10-year history
4th
percentile: 0 is its lowest day, 100 its highest
10-year range
11.2× to 52.6×
Peer median
23.7×

Zoetis' forward PE is 13.1× as of Oct 23, 2026.

That is below its ten-year median of 30.5×, lower than on 96% of days in the last ten years.

Over that time it ranged from 11.2× in Oct 2026 to 52.6× in Dec 2021.

The median for 10 healthcare stocks of a similar size is 23.7×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far13.1×11.2×20.9×
202519.8×18.6×28.5×
202427.4×25.9×35.5×
202335.2×28.4×35.7×
202229.0×26.4×45.5×
202152.6×34.7×52.6×
202040.4×30.8×44.0×
201940.4×26.1×40.4×
201826.1×25.2×31.4×
201727.7×24.1×28.2×
201627.0×24.8×30.8×
201531.9×28.7×35.4×
201432.0×20.4×32.6×
201323.5×22.1×26.2×

Against its peers

Companies in Healthcare nearest Zoetis' size, closest first, today.

CompanyForward PE
ZTSZoetis13.1×
MTDMettler-Toledo International33.9×
CNCCentene15.0×
GEHCGE HealthCare Technologies13.8×
RMDResMed20.8×
RPRXRoyalty Pharma12.9×
BIIBBiogen19.1×
ALNYAlnylam Pharmaceuticals26.7×
DXCMDexCom27.7×
WSTWest Pharmaceutical Services42.2×
ILMNIllumina47.2×
Peer median23.7×

Where Zoetis ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Zoetis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.